Gentury is a Boston-based preclinical drug discovery contract research organization. The company offers comprehensive technology platforms and expertise around Hit to Lead and Lead Optimization in preclinical drug discovery and development, which includes biological assays/assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. Gentury currently collaborates with many of the top world pharmaceutical companies, as well as many mid-sized pharmaceutical and biotech companies.

 

 

Gentury always strives to meet your demands, however challenging it may be. As experts in the Science and the Drug Discovery process, we streamlined our technologies and methods to feed the diversified and increasingly demanding needs of our clients with high quality and timely delivery.